Last Thursday, the FDA gave full approval to the first drug intended to treat COVID-19, but a recent Vox article suggests they may have put the cart ahead of the horse. Remdesivir is an antiviral drug developed by Gilead Sciences, and is marketed under the brand Veklury. It had previously received emergency use authorization back in May for severe COVID cases, and was allowed to be used on less serious cases when the FDA relaxed its guidelines in August.
Should the FDA Have Approved Remdesivir?
Researchers question the validity of the FDA’s first approved COVID-19 drug.
Oct 30, 2020
Recommended
Recommended
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Downloads
